Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Genfit stock
Learn how to easily invest in Genfit stock.
Genfit is a biotechnology business based in the US. Genfit shares (GNFT) are listed on the NASDAQ and all prices are listed in US Dollars. Genfit employs 122 staff and has a trailing 12-month revenue of around $94.2 million.
How to buy shares in Genfit
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GNFT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Genfit stock price (NASDAQ: GNFT)Use our graph to track the performance of GNFT stocks over time.
Genfit shares at a glance
|Latest market close||$4.04|
|52-week range||$3.01 - $6.38|
|50-day moving average||$4.29|
|200-day moving average||$4.02|
|Wall St. target price||N/A|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.10|
Buy Genfit shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Genfit stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Genfit price performance over time
|1 week (2022-09-28)||1.51%|
|1 month (2022-09-02)||-8.18%|
|3 months (2022-07-05)||20.24%|
|6 months (2022-04-05)||5.90%|
|1 year (2021-10-05)||7.73%|
|2 years (2020-10-05)||-11.01%|
|3 years (2019-10-04)||14.45|
|5 years (2017-10-01)||N/A|
Is Genfit stock undervalued or overvalued?
Valuing Genfit stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genfit's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genfit's P/E ratio
Genfit's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 3x. In other words, Genfit shares trade at around 3x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Genfit's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $47.5 million.
The EBITDA is a measure of a Genfit's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$94.2 million|
|Operating margin TTM||48.2%|
|Gross profit TTM||$85.6 million|
|Return on assets TTM||15.32%|
|Return on equity TTM||67.45%|
|Market capitalisation||$192.3 million|
TTM: trailing 12 months
Genfit share dividends
We're not expecting Genfit to pay a dividend over the next 12 months.
Genfit share price volatility
Over the last 12 months, Genfit's shares have ranged in value from as little as $3.01 up to $6.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genfit's is 1.2811. This would suggest that Genfit's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Genfit S. A. , a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.
Genfit in the news
GENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantis
GENFIT Reports First Half-Year 2022 Financial Results and Provides Corporate Update
Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
Frequently asked questionsWhat percentage of Genfit is owned by institutions?
Currently 4.17% of Genfit shares are held by institutions. How many people work for Genfit?
Latest data suggests 122 work at Genfit. When does the fiscal year end for Genfit?
Genfit's fiscal year ends in December. Where is Genfit based?
Genfit's address is: Parc EurasantE, Loos, France, 59120 What is Genfit's ISIN number?
Genfit's international securities identification number is: US3722791098 What is Genfit's CUSIP number?
Genfit's Committee on Uniform Securities Identification Procedures number is: 372279109
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert